5 October 2016Americas

LSIPR 50 2016: Patricia LiWang and Sir Paul Nurse

Name: Patricia LiWang

Organisation: UC Merced, University of California

Position: Professor

In 2011 Patricia LiWang discovered a new microbicide to stop HIV entering and infecting human cells through sexual transmission. It is thought to be 100 times more potent than current HIV inhibitors; the drug is a combination of two inhibitors, which it makes it more difficult for the HIV to mutate.

Since her initial discovery LiWang has continued her research on developing HIV inhibitors and in 2014 she was awarded a $2.3 million grant by the National Institute of Allergy and Infectious Diseases to continue her research for a further four years. LiWang suggested that her team was awarded the grant because proteins that work as drugs are uncommon in the pharmaceutical industry and the team’s work in that area represents a new field of innovation.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk